Publications of Sandra Nischwitz
All genres
Journal Article (8)
2023
Journal Article
16, 17562864231197309 (2023)
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
Journal Article
16, 17562864231197309 (2023)
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
Journal Article
Neural correlates of transient topographical disorientation: an experimental EEG-MRI case study. JOURNAL OF NEUROLOGY (2023)
2022
Journal Article
13, 915058 (2022)
Combined Fainting and Psychogenic Non-epileptic Seizures as Significant Therapy Hurdles in Blood-Injury-Injection Phobia: A Mini-Review and Case Report. FRONTIERS IN PSYCHIATRY 2020
Journal Article
16 (2), e1007616 (2020)
DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning. PLOS COMPUTATIONAL BIOLOGY
Journal Article
161 (4), pp. 787 - 796 (2020)
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. PAIN 2019
Journal Article
76 (7), pp. 841 - 849 (2019)
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. JAMA NEUROLOGY
Journal Article
266 (2), pp. 386 - 397 (2019)
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). JOURNAL OF NEUROLOGY Meeting Abstract (5)
2024
Meeting Abstract
30 (3), pp. 179 - 180. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, DENMARK, September 18, 2024 - September 20, 2024. (2024)
Progression independent of relapse activity in early RRMS - an analysis of the German NationMS cohort. In MULTIPLE SCLEROSIS JOURNAL,
Meeting Abstract
30 (3), pp. 308 - 309. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, DENMARK, September 18, 2024 - September 20, 2024. (2024)
Cytokines associated with disability progression over one year in a German monocentric MS cohort. In MULTIPLE SCLEROSIS JOURNAL, 2023
Meeting Abstract
29, pp. 435 - 436. 9th Joint ECTRIMS-ACTRIMS meeting, Milan, ITALY, October 11, 2023 - October 13, 2023. (2023)
Disease course and disease-modifying treatment in men and women with early MS from the German NationMS cohort. In MULTIPLE SCLEROSIS JOURNAL,
Meeting Abstract
29, pp. 892 - 893. 9th Joint ECTRIMS-ACTRIMS meeting, Milan, ITALY, October 11, 2023 - October 13, 2023. (2023)
Serum interleukin 16 levels probed as predictor of longitudinal global and regional brain volume and lesion volume changes in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL, 2019
Meeting Abstract
25, pp. 906 - 907. 35th Congress of the
European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
(ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, SWEDEN, September 11, 2019 - September 13, 2019. (2019)
Identification of functionally relevant genetic variants associated with multiple sclerosis using deep learning. In MULTIPLE SCLEROSIS JOURNAL,